Investor Conference Call Replay - Not bad, pretty goodI listened to the replay. I thought it was pretty good. They doubled their sales staff to 4 with 2 new coming on now and next month. Pace of acquisition deals should pick up with more face time in front of target clinic GI practices. Line of credit is there, pipeline of targets is good, no threat of rate cuts, new CEO sounds sharp. Not sold on the exploration of new incremental services so we will see where that goes. might be pleasantly surprised with some hidden value, but whatever, not counting on it. Of course we know they are buying back shares so that increases the value of our shares and proves they feel that the shares are undervalued. Im happy to hold because if they get bought out it would be at a much higher price than today. I can sleep at night with this, will most likely work out nicely.